$BDPT
BIOADAPTIVES, INC.

2021 Q4 Form 10-Q Financial Statement

#000164033421002736 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $3.850K $5.342K $4.439K
YoY Change 3.22% 20.34% 113.41%
Cost Of Revenue $2.710K $2.227K $3.388K
YoY Change 27.23% -34.27% 670.0%
Gross Profit $1.140K $3.115K $1.051K
YoY Change -28.75% 196.38% -35.91%
Gross Profit Margin 29.61% 58.31% 23.68%
Selling, General & Admin $137.2K $131.4K $25.71K
YoY Change 605.97% 411.05% -45.16%
% of Gross Profit 12032.46% 4217.98% 2446.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $41.71K $44.58K
YoY Change
% of Gross Profit 3658.77% 1431.14%
Operating Expenses $178.9K $176.0K $25.71K
YoY Change 820.64% 584.41% -45.16%
Operating Profit -$177.7K -$172.9K -$24.66K
YoY Change 896.86% 600.94% -45.49%
Interest Expense -$36.55K $64.54K $66.21K
YoY Change -75.24% -2.52% -785.43%
% of Operating Profit
Other Income/Expense, Net $138.3K $11.20K
YoY Change 1135.48%
Pretax Income -$214.3K -$34.52K -$13.46K
YoY Change 29.54% 156.38% -75.48%
Income Tax
% Of Pretax Income
Net Earnings -$214.3K -$34.52K -$13.46K
YoY Change 29.54% 156.38% -75.48%
Net Earnings / Revenue -5565.71% -646.13% -303.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$5.369K -$1.021K -$647.30
COMMON SHARES
Basic Shares Outstanding 38.78M shares 33.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $83.13K $66.68K $14.84K
YoY Change 1552.68% 349.33% 916.44%
Cash & Equivalents $82.94K $66.34K
Short-Term Investments $190.00 $340.00 $390.00
Other Short-Term Assets $1.000K $1.000K
YoY Change
Inventory $4.750K $9.601K $17.17K
Prepaid Expenses $1.000K $1.000K
Receivables
Other Receivables
Total Short-Term Assets $88.88K $77.28K $32.01K
YoY Change 371.59% 141.42% 121.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $59.71K $101.4K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $88.88K $77.28K $32.01K
Total Long-Term Assets $59.71K $101.4K $0.00
Total Assets $148.6K $178.7K $32.01K
YoY Change 688.42% 458.25% 121.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.750K $190.5K $70.25K
YoY Change 171.2% 82.23%
Accrued Expenses $10.99K $55.31K
YoY Change -76.18%
Deferred Revenue
YoY Change
Short-Term Debt $436.8K $479.9K $464.1K
YoY Change -9.55% 3.42% 93.52%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.242M $1.391M $1.285M
YoY Change -11.16% 8.24% 63.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.242M $1.391M $1.285M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.242M $1.391M $1.285M
YoY Change -11.16% 8.24% 63.65%
SHAREHOLDERS EQUITY
Retained Earnings -$6.656M -$6.442M
YoY Change 18.73%
Common Stock $5.082K $3.580K
YoY Change 135.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.093M -$1.212M -$1.253M
YoY Change
Total Liabilities & Shareholders Equity $148.6K $178.7K $32.01K
YoY Change 688.42% 458.25% 121.98%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$214.3K -$34.52K -$13.46K
YoY Change 29.54% 156.38% -75.48%
Depreciation, Depletion And Amortization $41.71K $44.58K
YoY Change
Cash From Operating Activities -$35.40K -$33.18K -$34.48K
YoY Change 259.03% -3.77% 6.52%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 52.00K 30.00K 44.93K
YoY Change -33.23% 117.47%
NET CHANGE
Cash From Operating Activities -35.40K -33.18K -34.48K
Cash From Investing Activities
Cash From Financing Activities 52.00K 30.00K 44.93K
Net Change In Cash 16.60K -3.180K 10.45K
YoY Change -268.36% -130.43% -189.24%
FREE CASH FLOW
Cash From Operating Activities -$35.40K -$33.18K -$34.48K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
444 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
9601 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
13815 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
77278 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
18846 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
338 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38778679 shares
CY2021Q3 us-gaap Cash
Cash
66339 USD
CY2020Q4 us-gaap Cash
Cash
4587 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1000 USD
CY2021Q3 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
101417 USD
CY2020Q4 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
0 USD
CY2021Q3 us-gaap Assets
Assets
178695 USD
CY2020Q4 us-gaap Assets
Assets
18846 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
190518 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87561 USD
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
720531 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
827119 USD
CY2021Q3 bdpt Convertible Notes Net Of Discount
ConvertibleNotesNetOfDiscount
43783 USD
CY2020Q4 bdpt Convertible Notes Net Of Discount
ConvertibleNotesNetOfDiscount
4764 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
446217 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
405236 USD
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
33715 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
77715 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1390981 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1397631 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1390981 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1397631 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35800045 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21591942 shares
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10000 shares
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
762390 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3580 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2159 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5225800 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4225217 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6441826 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5606161 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1212286 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1378785 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178695 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18846 USD
CY2021Q3 us-gaap Revenues
Revenues
5342 USD
CY2020Q3 us-gaap Revenues
Revenues
4439 USD
us-gaap Revenues
Revenues
15925 USD
us-gaap Revenues
Revenues
12596 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2227 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
3388 USD
us-gaap Cost Of Revenue
CostOfRevenue
6962 USD
us-gaap Cost Of Revenue
CostOfRevenue
8105 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
3115 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
1051 USD
us-gaap Gross Profit
GrossProfit
8963 USD
us-gaap Gross Profit
GrossProfit
4491 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
110456 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13362 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
152776 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61288 USD
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
20929 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
12349 USD
us-gaap Professional Fees
ProfessionalFees
58551 USD
us-gaap Professional Fees
ProfessionalFees
40060 USD
CY2021Q3 bdpt Stock Based Compensation
StockBasedCompensation
0 USD
CY2020Q3 bdpt Stock Based Compensation
StockBasedCompensation
0 USD
bdpt Stock Based Compensation
StockBasedCompensation
163900 USD
bdpt Stock Based Compensation
StockBasedCompensation
139643 USD
CY2021Q3 bdpt Amortization Of License
AmortizationOfLicense
44583 USD
CY2020Q3 bdpt Amortization Of License
AmortizationOfLicense
0 USD
bdpt Amortization Of License
AmortizationOfLicense
92083 USD
bdpt Amortization Of License
AmortizationOfLicense
0 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
175968 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
25711 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-491903 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1042676 USD
us-gaap Operating Expenses
OperatingExpenses
467310 USD
us-gaap Operating Expenses
OperatingExpenses
240991 USD
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-423 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
328 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-106 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-381 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
64543 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
66213 USD
us-gaap Interest Expense
InterestExpense
141792 USD
us-gaap Interest Expense
InterestExpense
178717 USD
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
203303 USD
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
77082 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-184420 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-266222 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
138337 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11197 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-377318 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-445320 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34516 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13463 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-835665 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-681820 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-34516 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13463 USD
us-gaap Net Income Loss
NetIncomeLoss
-681820 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33818539 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20794026 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31687123 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20289158 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1378785 USD
CY2021Q1 bdpt Series A Preferred Stock Issued For Settlement Of Debt Related Party Amount
SeriesAPreferredStockIssuedForSettlementOfDebtRelatedPartyAmount
75000 USD
CY2021Q1 bdpt Series A Preferred Stock Issued For License Fee Amount
SeriesAPreferredStockIssuedForLicenseFeeAmount
102500 USD
CY2021Q1 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
486612 USD
CY2021Q1 bdpt Common Stock Issued For Service Amount
CommonStockIssuedForServiceAmount
163900 USD
CY2021Q1 bdpt Cancellation Of Common Stock Officers Amount
CancellationOfCommonStockOfficersAmount
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-309246 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1351922 USD
CY2021Q3 bdpt Series A Preferred Stock Issued For License Fee Amount
SeriesAPreferredStockIssuedForLicenseFeeAmount
91000 USD
CY2021Q3 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
83152 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-34516 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1212286 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-839876 USD
CY2020Q1 bdpt Common Stock Issued For Service Amount
CommonStockIssuedForServiceAmount
47115 USD
CY2020Q1 bdpt Common Stock Issued For Service Related Party Amount
CommonStockIssuedForServiceRelatedPartyAmount
36000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10264 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-237922 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-984419 USD
CY2020Q2 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
44380 USD
CY2020Q2 bdpt Common Stock Issued For Service Related Party Amount
CommonStockIssuedForServiceRelatedPartyAmount
36000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10264 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-430435 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1324210 USD
CY2020Q3 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
84572 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13463 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
61752 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
2136 USD
CY2020Q4 us-gaap Cash
Cash
4587 USD
CY2019Q4 us-gaap Cash
Cash
12313 USD
CY2021Q3 us-gaap Cash
Cash
66339 USD
CY2020Q3 us-gaap Cash
Cash
14449 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-835665 USD
us-gaap Net Income Loss
NetIncomeLoss
-681820 USD
us-gaap Share Based Compensation
ShareBasedCompensation
163900 USD
us-gaap Share Based Compensation
ShareBasedCompensation
47115 USD
bdpt Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
0 USD
bdpt Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
92528 USD
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
184420 USD
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
266222 USD
bdpt Amortization Of License
AmortizationOfLicense
92083 USD
bdpt Amortization Of License
AmortizationOfLicense
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
98481 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
140937 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-106 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-381 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4214 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6042 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1000 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
119213 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
43652 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-123248 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-97027 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
9800 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-18352 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1623 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1623 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
27715 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
20000 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
205000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
80000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
185000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
99163 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
16424 USD
us-gaap Interest Paid Net
InterestPaidNet
1079 USD
bdpt Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
120000 USD
bdpt Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
0 USD
bdpt Issuance Of Common Stock For Conversion Of Debt
IssuanceOfCommonStockForConversionOfDebt
569764 USD
bdpt Issuance Of Common Stock For Conversion Of Debt
IssuanceOfCommonStockForConversionOfDebt
128952 USD
bdpt Issuance Series A Preferred Stock For License Fee
IssuanceSeriesAPreferredStockForLicenseFee
193500 USD
bdpt Issuance Series A Preferred Stock For License Fee
IssuanceSeriesAPreferredStockForLicenseFee
0 USD
bdpt Issuance Series A Preferred Stock For Settlement Of Debt Related Party
IssuanceSeriesAPreferredStockForSettlementOfDebtRelatedParty
60 USD
bdpt Issuance Series A Preferred Stock For Settlement Of Debt Related Party
IssuanceSeriesAPreferredStockForSettlementOfDebtRelatedParty
0 USD
bdpt Cancellation Of Common Stock
CancellationOfCommonStock
35 USD
bdpt Cancellation Of Common Stock
CancellationOfCommonStock
0 USD
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
720531 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
444 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
827119 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
444 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
92083 USD
bdpt License Cost
LicenseCost
101417 USD
CY2021Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
990 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
5374 USD
CY2021Q3 bdpt Credit Card
CreditCard
0 USD
CY2020Q4 bdpt Credit Card
CreditCard
7759 USD
CY2021Q3 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
118333 USD
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
60214 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
49583 USD
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10981 USD
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
24845 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
190518 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company, and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
338 USD
CY2021Q3 bdpt Convertible Notes Payable Before Unamortized Debt Discount
ConvertibleNotesPayableBeforeUnamortizedDebtDiscount
490000 USD
CY2020Q4 bdpt Convertible Notes Payable Before Unamortized Debt Discount
ConvertibleNotesPayableBeforeUnamortizedDebtDiscount
410000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
43783 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4764 USD
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
446217 USD
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
405236 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
446217 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
405236 USD
CY2021Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
bdpt Amortization Expenses
AmortizationExpenses
41847 USD
bdpt Amortization Expenses
AmortizationExpenses
34852 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
98481 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
143392 USD
bdpt Beginning Balance
BeginningBalance
827119 USD
bdpt Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
120000 USD
bdpt Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
143392 USD
bdpt Settled On Issuance Of Common Stock
SettledOnIssuanceOfCommonStock
-411008 USD
bdpt Ending Balance
EndingBalance
720531 USD
bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
143392 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6441826 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
338 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87561 USD
bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
132593 USD
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
41028 USD
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
133629 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
184420 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
266222 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
5:1 ratio
bdpt Shares Issued Upon Considerations Transferred
SharesIssuedUponConsiderationsTransferred
13560493 shares
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
569764 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
20000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Interest Paid
InterestPaid
1464 USD
us-gaap Interest Paid
InterestPaid
1850 USD
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
33715 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
77715 USD
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.04 pure
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55312 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46145 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
140937 USD
CY2021Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
263392 USD
CY2021Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
120000 USD
CY2021Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
4902 USD
CY2020Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
3438 USD
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
118333 USD
CY2021Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
5756251 shares

Files In Submission

Name View Source Status
0001640334-21-002736-index-headers.html Edgar Link pending
0001640334-21-002736-index.html Edgar Link pending
0001640334-21-002736.txt Edgar Link pending
0001640334-21-002736-xbrl.zip Edgar Link pending
bdpt-20210930.xsd Edgar Link pending
bdpt-20210930_cal.xml Edgar Link unprocessable
bdpt-20210930_def.xml Edgar Link unprocessable
bdpt-20210930_lab.xml Edgar Link unprocessable
bdpt-20210930_pre.xml Edgar Link unprocessable
bdpt_10q.htm Edgar Link pending
bdpt_10qimg1.jpg Edgar Link pending
bdpt_10q_htm.xml Edgar Link completed
bdpt_ex311.htm Edgar Link pending
bdpt_ex312.htm Edgar Link pending
bdpt_ex321.htm Edgar Link pending
bdpt_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending